Co-Diagnostics, a Salt Lake City-based testing company, has been slapped with a hefty fine of $250,000 by the U.S. Securities and Exchange Commission (SEC) for engaging in deceptive practices and failing to disclose crucial information to investors. The SEC's order highlights Co-Diagnostics' misleading claims about their COVID tests and their failure to disclose payments made to top executives' family members. . .
Testing Company Fined For Misleading Investors, Failing To Disclose Payments
Co-Diagnostics' Misleading Claims About Their COVID Tests